Description
Form: Ready to use vial | Purity: ≥99% | Storage: Refrigerate
What It Is
Cagrilinitide is a long-acting amylin analog. Amylin is a hormone co-secreted with insulin from the pancreas after meals. It reduces appetite, slows gastric emptying, and regulates blood sugar. Cagrilinitide has a half-life of about 7 days, making it suitable for once-weekly dosing.
What It Does
Cagrilinitide reduces appetite, slows digestion, lowers post-meal blood sugar spikes, and produces meaningful fat loss. In combination with semaglutide (the CagriSema combination), Phase 3 trials have shown up to 25 percent body weight reduction, making it one of the most powerful metabolic combinations in development.
How It Works
Cagrilinitide activates amylin receptors in the brain and gut, reducing appetite signals and slowing gastric emptying. When combined with GLP-1 agonists, the two pathways work synergistically through different but complementary mechanisms, producing greater fat loss than either compound alone.
Who Benefits Most
People who want to combine amylin and GLP-1 pathways for maximum metabolic effect. People who have plateaued on GLP-1 therapy alone. People with significant insulin resistance or post-meal blood sugar dysregulation. Best used as part of a comprehensive metabolic protocol.
Protocol and Dosing
Typical dose: 0.3 to 2.4 mg injected subcutaneously once weekly. Often combined with semaglutide. Titrate slowly. Cycle length: 16 to 52 weeks.
| Vial Format | Typical Starting Dose | Maintenance Dose |
|---|---|---|
| Standard vial | 0.3 mg once weekly | 1.2 to 2.4 mg once weekly |
Cautions
May cause nausea, vomiting, or injection site reactions. Titrate slowly. Same general precautions as GLP-1 compounds. Not recommended during pregnancy.
Pairs Well With
Semaglutide is the primary combination partner (CagriSema). Tirzepatide for additional GIP receptor activation. MOTS-C for mitochondrial and metabolic synergy.
Quality and Sourcing
Sourced through United Medical Services (UMS), a compounding facility built to the same standards as a licensed 503A pharmacy. Every batch is tested for purity, sterility, potency, and identity. Certificates of Analysis are available on request.
- HPLC purity testing
- LC-MS identity confirmation
- Sterility and endotoxin testing
- Heavy metals screening
- Purity: greater than or equal to 99%
For research and investigational use by qualified healthcare practitioners only. Not for human consumption. Not for resale. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease. Certificate of Analysis available on request. Questions? Call or text 507-382-2881.
Reviews
There are no reviews yet.